$
55.520
-0.050(-0.090%)
  • Overview
  • Forecast
  • Valuation
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
57.190
Open
56.655
VWAP
55.46
Vol
7.89M
Mkt Cap
37.92B
Low
54.250
Amount
437.51M
EV/EBITDA(TTM)
12.86
Total Shares
696.98M
EV
42.76B
EV/OCF(TTM)
18.62
P/S(TTM)
2.59

Corteva, Inc. is a global pure-play agriculture company. The Company is a global provider of seed and crop protection solutions focused on the agriculture industry and contributing to a healthier food supply. The Company's Seed segment is developing ...Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q1
FY2025Q2
FY2025Q3
4.56B
+1.53%
0.881
-0.98%
6.28B
+2.72%
1.956
+6.89%
2.39B
+2.65%
-0.334
-31.86%
Estimates Revision
The market is revising Downward the revenue expectations for Corteva, Inc. (CTVA) for FY2025, with the revenue forecasts being adjusted by -0.44% over the past three months. During the same period, the stock price has changed by -2.85%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.44%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-6.81%
In Past 3 Month
Stock Price
Go Down
down Image
-2.85%
In Past 3 Month
14 Analyst Rating
up Image
25.67% Upside
Wall Street analysts forecast CTVA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CTVA is 69.77 USD with a low forecast of 59.00 USD and a high forecast of 74.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Buy
4 Hold
0 Sell
Moderate Buy
up Image
25.67% Upside
Current: 55.520
sliders
Low
59.00
Averages
69.77
High
74.00
Argus Research
Bill Selesky
Hold
to
Strong Buy
Upgrades
$69
2025-03-31
Reason
Argus analyst Bill Selesky upgraded Corteva to Buy from Hold with a $69 price target.
Goldman Sachs
Duffy Fischer
Strong Buy
Initiates
$71
2025-03-13
Reason
Goldman Sachs initiated coverage of Corteva with a Buy rating and $71 price target, implying 20% upside. The company is a "high-quality" seed and crop protection business that is intellectual property protected and research and development heavy, so there are "formidable barriers to entry" with EBITDA margins in the low 20s, the analyst tells investors in a research note. The firm believes Corteva's premium valuation is warranted and that there is room for the multiple to continue to grow as investors favor the defensive names.
B of A Securities
Steve Byrne
Strong Buy
Maintains
$69 → $73
2025-02-11
Reason
Keybanc
Aleksey Yefremov
Buy
Maintains
$68 → $70
2025-02-07
Reason
Oppenheimer
Kristen Owen
Buy
Maintains
$70 → $72
2025-02-07
Reason
RBC Capital
Arun Viswanathan
Buy
Maintains
$72 → $73
2025-02-07
Reason
Citigroup
Patrick Cunningham
Strong Buy
Maintains
$69 → $74
2025-01-29
Reason
Wells Fargo
Richard Garchitorena
Buy
Maintains
$67 → $73
2025-01-28
Reason
Barclays
Benjamin Theurer
Hold
Maintains
$62 → $64
2025-01-21
Reason
Barclays analyst Benjamin Theurer raised the firm's price target on Corteva to $64 from $62 and keeps an Equal Weight rating on the shares. Entering 2025, the firm is more optimistic about crop protection and maintains a positive outlook on diversified international protein names and ingredients. In contrast, Barclays adds caution to its grain processor coverage and adjusted ratings in fertilizer given the recent run-up in share prices. It recognizes the strength in potash volumes in 2024 did not bring stock appreciation for the major potash players.
Keybanc
Aleksey Yefremov
Buy
Maintains
$69 → $68
2025-01-10
Reason
KeyBanc lowered the firm's price target on Corteva to $68 from $69 and keeps an Overweight rating on the shares. The firm struggles to identify concrete reasons for optimism for 2025 in Chemicals, and sees more uncertainty around 2025 for chemicals than in 2024, including FX headwinds, tariffs, uneven autos and housing, and the risk of labor and materials inflation, the analyst tells investors in a research note. In commodities, given persistent overcapacity, the firm does not see margins meaningfully improving over the next 12 months.

Valuation Metrics

The current forward P/E ratio for Corteva Inc (CTVA.N) is 18.84, compared to its 5-year average forward P/E of 19.89. For a more detailed relative valuation and DCF analysis to assess Corteva Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
19.89
Current PE
18.84
Overvalued PE
21.92
Undervalued PE
17.87

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average EV/EBITDA
11.68
Current EV/EBITDA
10.27
Overvalued EV/EBITDA
12.93
Undervalued EV/EBITDA
10.43

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
2.13
Current PS
2.20
Overvalued PS
2.44
Undervalued PS
1.81

Financials

Annual
Quarterly
FY2024Q4
YoY :
+7.31%
3.98B
Total Revenue
FY2024Q4
YoY :
+118.00%
218.00M
Operating Profit
FY2024Q4
YoY :
-78.35%
-50.00M
Net Income after Tax
FY2024Q4
YoY :
-83.33%
-0.06
EPS - Diluted
FY2024Q4
YoY :
-5.77%
3.99B
Free Cash Flow
FY2024Q4
YoY :
+5.34%
33.13
Gross Profit Margin - %
FY2024Q4
YoY :
+42.55%
10.05
FCF Margin - %
FY2024Q4
YoY :
-79.78%
-1.26
Net Margin - %
FY2024Q4
YoY :
+13.99%
3.91
ROIC

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
4.7M
USD
2
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
4.8M
USD
3
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
8.7M
Volume
10
6-9
Months
0.0
Volume
0
0-12
Months
13.3M
Volume
12
Bought
0-3
0
0.0
Volume
Months
3-6
6
6.8M
Volume
Months
6-9
0
0.0
Volume
Months
0-12
14
8.4M
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
16.0K
USD
2
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

CTVA News & Events

Events Timeline
2025-02-11 (ET)
2025-02-11
07:45:01
Largest borrow rate increases among liquid names
select
2024-11-19 (ET)
2024-11-19
11:33:38
Corteva unveils financial framework through 2027
select
2024-11-19
07:16:51
Corteva announces new $3B share repurchase program
select
2024-11-18 (ET)
2024-11-18
07:23:17
Corteva announces intent to partner with bp
select
2024-11-06 (ET)
2024-11-06
15:49:05
Corteva sees 2024 operating $2.50-$2.60, consensus $2.67
select
2024-11-06
15:48:08
Corteva reports Q3 EPS (49c), consensus (30c)
select
2024-09-24 (ET)
2024-09-24
12:33:47
Corteva says top end of FY24 EBITDA guidance 'probably off the table'
select
2024-09-17 (ET)
2024-09-17
08:10:04
Corteva to invest $25M in Pairwise for gene editing in agriculture
select
News
8.0
04-01NASDAQ.COM
Corteva Cumulative Preferred Stock About To Put More Money In Your Pocket
4.5
03-31NASDAQ.COM
Equity Markets Recover on Strength in Defensive Stocks and Energy Producers
4.0
03-31SeekingAlpha
Corteva upgraded at Argus Research on improved demand trends
4.0
03-28NASDAQ.COM
S&P 500 Analyst Moves: CTVA
6.0
03-24Business Insider
Corteva (CTVA): New Buy Recommendation for This Basic Materials Giant
4.0
03-14Business Insider
Berenberg Bank Keeps Their Hold Rating on Corteva (CTVA)
6.0
03-13Benzinga
Goldman Sachs Agri Stock Picks: Corteva's R&D Edge, FMC's Pipeline, And Mosaic's Phosphate Advantage Set Up Strong Growth
2.0
03-13NASDAQ.COM
Is Corteva Stock Outperforming the Dow?
6.0
03-13Investing.com
Goldman Sachs starts coverage on agriculture chemical stocks By Investing.com
6.0
03-13CNBC
Here are Thursday's biggest analyst calls: Nvidia, Apple, Boeing, Wells Fargo, Microsoft, Amazon & more
6.0
03-13Benzinga
Goldman Sachs Initiates Coverage On Corteva with Buy Rating, Announces Price Target of $71
8.0
03-10Benzinga
China Hits Its Largest US Import, Soybeans, With Tariffs Along With Other Agricultural Products: Here's A List Of Stocks, ETFs That Could Be Impacted
4.0
03-06Business Insider
Corteva (CTVA): New Buy Recommendation for This Basic Materials Giant
8.0
03-04SeekingAlpha
Trump defends tariffs after markets close significantly down
5.0
03-04PRnewswire
Siteimprove Appoints Nayaki Nayyar as New Chief Executive Officer
5.0
02-21NASDAQ.COM
Insider Sale: Chief Executive Officer of $CTVA Sells 46,905 Shares
1.0
02-19PRnewswire
Corteva to Participate in Bank of America Global Agriculture & Materials Conference
7.0
02-14WSJ
Farm Companies’ Bottom Lines Suffer Amid Uncertainty; but Lower Costs May Be on the Horizon
7.0
02-14WSJ
Farm Companies Bottom Lines Suffer Amid Uncertainty; but Lower Costs May Be on the Horizon
8.5
02-12Investing.com
Germany's BASF considers listing agricultural chemicals unit in US or Germany, Bloomberg News reports By Reuters

FAQ

arrow icon

What is Corteva Inc (CTVA) stock price today?

The current price of CTVA is 55.52 USD — it has decreased -0.09 % in the last trading day.

arrow icon

What is Corteva Inc (CTVA)'s business?

arrow icon

What is the price predicton of CTVA Stock?

arrow icon

What is Corteva Inc (CTVA)'s revenue for the last quarter?

arrow icon

What is Corteva Inc (CTVA)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Corteva Inc (CTVA)'s fundamentals?

arrow icon

How many employees does Corteva Inc (CTVA). have?

arrow icon

What is Corteva Inc (CTVA) market cap?